Wealth Enhancement Advisory Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$922K	Buy	7,778 +500	+7%	+$54.1K	﹤0.01%	2134
2026 Q1	$750K	Sell	7,278 -84	-1%	-$8.87K	﹤0.01%	2012
2025 Q4	$769K	Hold	7,362	–	–	﹤0.01%	2136
2025 Q3	$700K	Sell	7,362 -100	-1%	-$8.75K	﹤0.01%	2105
2025 Q2	$607K	Sell	7,462 -535	-7%	-$42.7K	﹤0.01%	2082
2025 Q1	$693K	Sell	7,997 -367	-4%	-$31.3K	﹤0.01%	1830
2024 Q4	$691K	Buy	8,364 +635	+8%	+$54.6K	﹤0.01%	1764
2024 Q3	$672K	Hold	7,729	–	–	﹤0.01%	1627
2024 Q2	$635K	Hold	7,729	–	–	﹤0.01%	1492
2024 Q1	$620K	Buy	7,729 +1,438	+23%	+$111K	﹤0.01%	1464
2023 Q4	$479K	Sell	6,291 -1,450	-19%	-$104K	﹤0.01%	1533
2023 Q3	$560K	Buy	+7,741	New	+$593K	﹤0.01%	1367

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Wealth Enhancement Advisory Services's PJP Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Invesco Pharmaceuticals ETF (PJP) stake by 6.9% in Q2 2026, buying an estimated $54.1K and bringing the position to 7,778 shares worth $922K. The position accounts for ﹤0.01% of the portfolio, ranked #2134.

Wealth Enhancement Advisory Services first reported a position in PJP in Q3 2023 and has held it in 12 quarters since. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Wealth Enhancement Advisory Services held 7,778 shares of Invesco Pharmaceuticals ETF worth $922K as of Q2 2026.
Wealth Enhancement Advisory Services bought 500 Invesco Pharmaceuticals ETF shares in Q2 2026, an estimated $54.1K.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2134 holding.
Wealth Enhancement Advisory Services first reported a position in Invesco Pharmaceuticals ETF in Q3 2023 and has held it in 12 quarters since.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.